Our vision to develop a portfolio of viral and nonviral DNA delivery systems that provide new and better ways to deliver DNA into cells, tissues and organisms.
Traditional molecular biology techniques do not facilitate easy, modular assembly and disassembly of DNA parts for creation of new cellular systems for transient delivery of multicomponent heterologous DNA cargoes, or for the stable redesign of larger sections of the genome. Geneva Biotech develops technology platforms that allow scientists to create novel biological circuits for a wide variety of applications: including fundamental biological sciences research, drug discovery, and industrial biotechnology.
